FHAM
CRL icon

Folger Hill Asset Management’s Charles River Laboratories CRL Stock Holding History

Folger Hill Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,120
Closed -$417K – 200
2017
Q2 		$417K Hold
4,120
– – 0.04% 222
2017
Q1 		$371K Buy
4,120
+608
+17% +$51.6K 0.03% 258
2016
Q4 		$268K Buy
+3,512
New +$267K 0.02% 253

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Folger Hill Asset Management's CRL Position: Q3 2017 in Review

Folger Hill Asset Management sold out of Charles River Laboratories (CRL) in Q3 2017, closing a stake of 4,120 shares — an estimated $417K sold.

Folger Hill Asset Management first reported a position in CRL in Q4 2016 and held it in 3 quarters. The position peaked at $417K in Q2 2017. 336 funds tracked by Wall St. Rank hold CRL as of Q3 2017.

  • Folger Hill Asset Management reported no remaining Charles River Laboratories position as of Q3 2017 after selling out during the quarter.
  • Folger Hill Asset Management sold 4,120 Charles River Laboratories shares in Q3 2017, an estimated $417K.
  • Folger Hill Asset Management first reported a position in Charles River Laboratories in Q4 2016 and held it in 3 quarters.
  • Folger Hill Asset Management's Charles River Laboratories position peaked at $417K in Q2 2017.
  • 336 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2017.

Based on Folger Hill Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.